Skip to main content
Caplight Logo









Neurocia SAS

Neurocia SAS

Private
MontlaurHealthcare & Life Scienceshttps://neuropod.eu

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Neurocia SAS is a medtech company that develops non-invasive radiofrequency neuromodulation devices to treat neurodegenerative disorders such as Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

neuromodulationwearable medical devicebrain stimulationneurotechAlzheimer's treatmentphotobiomodulationgamma-frequency entrainmentradiofrequency stimulationat-home medical deviceneurodegenerative diseasemedtechclinical trialsnon-invasive brain stimulationdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurocia SAS Comparables

Compare Neurocia SAS with similar companies based on industry and business-model similarity.

Neurocia SAS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
REGEnLIFE
83%
NeuroEM Therapeutics
82%
Bottneuro AG
81%

Neurocia SAS Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 56% MoM.

  • Mar 2, 2026

    Monthly visitors increased 72% MoM.

Neurocia SAS Filings

Explore SEC and related filing metadata, where available.

Neurocia SAS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neurocia SAS's valuation, stock price, and market status.

Is Neurocia SAS a public or private company?

Neurocia SAS is a private company.

What is the current stock price of Neurocia SAS?

Neurocia SAS is a private company with no public stock price. Caplight tracks Neurocia SAS's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Neurocia SAS worth (valuation)?

Valuation information for Neurocia SAS is not publicly available.

Can I buy Neurocia SAS stock?

Neurocia SAS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neurocia SAS's last funding round?

Funding round information for Neurocia SAS is not publicly available.

Who are the main investors in Neurocia SAS?

Investor information for Neurocia SAS is not publicly disclosed.

Will Neurocia SAS IPO soon?

No public IPO plans have been announced for Neurocia SAS.

How can I track Neurocia SAS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurocia SAS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontlaur
Employee Range1
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?